Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This study aims to compare the effect of antiviral therapy with entecavir or tenofovir for
hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy. Included
patients will randomly divide into two groups.